Targeting KRAS-G12C(ON) and Potential Application to Overcoming Drug Resistance in RAS-Addicted Tumors September 22, 2021 Bob Nichols 3rd Annual RAS-Targeted Drug Development Summit; September 21-23, 2021; held virtually Download presentation